For the last few weeks, Wayne and I have been explaining why small-cap stocks are one of the best ways to make big gains, fast.
But not just any kind of small-caps… instead, small-caps from one specific sector.
Well, today I’m going to reveal the details about this sector…
Then I’ll show you how this one corner of the market could help you earn tremendous profits — without any of the typical drawbacks of investing in stocks.
You see, you’re about to discover how to get in on massive stock moves… with perfect timing… and walk away with gains as high as 1,311%.
So, are you ready?
The Most Profitable Market Sector
The sector I’m referring to is biotech.
We believe every investor needs to own biotech stocks right now. No exceptions.
I realize this flies in the face of conventional wisdom. Most mainstream “financial experts” say biotech stocks are too risky for investors like you.
But over the years, we’ve learned something about conventional Wall Street wisdom: it’s usually dead wrong!
Or as the famous contrarian Humphrey B. Neill observed, “When everyone thinks alike, everyone is likely to be wrong.”
And this observation has never been truer than it is right now with biotech stocks.
You see, momentum is on our side here. Biotech is the sector that snapped back the quickest from the Coronavirus sell-off, and now it keeps hitting new all-time highs.
Furthermore, the paradigm around this sector has shifted permanently. After all, it’s now become clear that biotechs are absolutely vital to human survival.
Case in point: without biotech research and development, Pfizer wouldn’t have been able to announce a potential vaccine for Covid-19 earlier this week.
But as Wayne and I have tried to make clear in these columns over the past few weeks, for investors like you, one hurdle stands in the way of pocketing big, fast biotech profits:
Knowing which stocks to buy, and knowing when to buy and sell them.
And that’s where a strategy our partner Lou Basenese discovered comes into the picture…
The Secret of “Stock Market Tracking Numbers”
If you’ve ever shopped on Amazon.com, you probably know that you can track your order.
Tracking helps you understand when your package will ship, and when it’s expected to arrive at your front door.
It’s the same thing with UPS, USPS, and FedEx. They all let you track where your package is, and when it will be delivered.
Well, as it turns out, Lou discovered that a similar system exists in the biotech sector — but instead of it being used to deliver packages, it can be used to deliver profits.
You see, because of a Federal program championed by former President Ronald Reagan, the U.S. government assigns “tracking numbers” to specific biotech stocks.
And these numbers can help us to:
- Identify a date in the near future to expect a major price move.
- Place a simple buy order for the stock before that date arrives.
- Cash out with big gains.
To be clear, not all stocks have these “tracking numbers.” But the ones that do can consistently deliver big profits, just like clockwork.
In fact, over the past 12 months alone, 261 stocks with these numbers have experienced price moves of 100% or greater.
That’s why, as Lou says, “Understanding how these numbers work is the closest thing to having legal ‘inside information’ as I’ve ever seen.”
And now Lou believes you should learn how to use them, too.
That’s why, next week, he’s decided to host a special event…
Join the Countdown to Pocket 1,311% Profits
During this exclusive presentation, Lou will reveal exactly where to find these “tracking numbers,” and exactly how to look them up yourself.
Then, as he told us:
“I’m going to blow the lid off a specific tracking number you can get into right now…”
On this single trade, he believes investors could potentially earn profits as high as 1,311% — by Dec. 5.
And lastly, he’ll be telling viewers about 2 other “tracking numbers” he expects to explode in the next 3 months.
To watch Lou present all this information on video, simply sign up for his event now.
Registration is FREE for all readers of Crowdability, but spots are limited.